Evidence map›Paper›PMID 29590151›Full record

ArticlePloS one2018

Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study.

Dina Terloyeva, Zhamilya Nugmanova, Gulzhakhan Akhmetova, Aikan Akanov, Nimish Patel, Victoria Lazariu, Lisa Norelli, Louise-Anne McNutt

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dina TerloyevaDepartment of HIV infection and Infection Control, Asfendiyarov Kazakh National Medical University (KNMU), Almaty, Kazakhstan.ORCID 0000-0002-7815-0004
Zhamilya NugmanovaDepartment of HIV infection and Infection Control, Asfendiyarov Kazakh National Medical University (KNMU), Almaty, Kazakhstan.
Gulzhakhan AkhmetovaAlmaty City AIDS Centre, Almaty, Kazakhstan.
Aikan AkanovDepartment of Public Health, Asfendiyarov Kazakh National Medical University (KNMU), Almaty, Kazakhstan.
Nimish PatelAlbany College of Pharmacy & Health Sciences, Albany, New York, United States of America.
Victoria LazariuDepartment of Epidemiology and Biostatistics, University at Albany, State University of New York, Rensselaer, New York, United States of America.
Lisa NorelliDepartment of Psychiatry, Albany Medical College, Albany, New York, United States of America.
Louise-Anne McNuttInstitute for Health and the Environment, University at Albany, State University of New York, Rensselaer, New York, United States of America.

Funding

Training in the Epidemiology of HPV/Cervical Neoplasia Among HIV+ WomenD43TW000233 · FIC · SUNY DOWNSTATE MEDICAL CENTER · PI DEHOVITZ, JACK A · 1993 to 2015
$10.1M
FIC NIH HHS D43 TW000233NIH HHS D43 TW000233
6 · The paper itself

Abstract

backgroundIn Kazakhstan, scarce official prevalence data exists for mood disorders. This study investigates the occurrence of depressive symptoms among people living with HIV/AIDS (PLWHA), and the relationship between depressive symptoms, HIV treatment initiation and antiretroviral treatment (ART) adherence.

methodsA cross-sectional study was conducted among patients seen at the Almaty AIDS Center between April and December 2013. Two data sources were used: 1) self-administered survey that included the Patient Health Questionnaire (PHQ-9) to capture depression symptoms and 2) medical record review. Two primary outcomes were evaluated with log-binomial models and Fisher's exact test: the relationship between depression symptoms and 1) HIV treatment group, and 2) HIV adherence.

resultsOf the 564 participants, 9.9% reported symptoms consistent with a depressive disorder. None had received treatment for depression. Among those not on ART, a relationship between depressive symptoms and low CD4 counts (≤ 350 cells/mm3) was evident (7.1% for CD4 ≤ 350 cells/mm3 vs. 0.9% for CD4 > 350 cells/mm3, p = 0.029). In multivariable analysis, a higher prevalence of depressive symptoms was statistically associated with ART treatment, positive hepatitis C virus (HCV) status, and being unmarried. For those taking ART, treatment adherence was not statistically associated with a lower prevalence of depressive symptoms (12.5% vs 20.0%, p = 0.176); limited power may have impacted statistical significance.

conclusionsUntreated depression was found among PLWHA suggesting the need to evaluate access to psychiatric treatment. A collaborative strategy may be helpful to optimize HIV treatment outcomes.

Indexed as

Acquired Immunodeficiency SyndromeAdolescentAdultAnti-Retroviral AgentsCross-Sectional StudiesDepressionDepressive DisorderFemaleHIV InfectionsHumansKazakhstanMaleMiddle AgedPrevalenceYoung AdultAnti-Retroviral Agents

Identifiers

PMID29590151
PMCPMC5873996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.